(15206898), H. J. J., (15053070), G. H., (15206901), A. W. M., (15206904), Z. M., (15019395), E. A. R., (15206907), T. H., . . . (15044781), E. R. P. (2025). Supplementary Tables 1 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(15206898), H. Josh Jang, et al. Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy. 2025.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(15206898), H. Josh Jang, et al. Supplementary Tables 1 from A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing After Initial Immune Checkpoint Inhibitor Therapy. 2025.